Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Navigating Henry Schein – An Investor Brief

Shares of Health Care sector company Henry Schein moved -3.4% today, and are now trading at a price of $70.93. The Mid-Cap stock's daily volume was 1,835,340 compared to its average volume of 1,511,010. The S&P 500 index returned a 0.0% performance.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. The company is based in Melville and has 25,000 full time employees. Its market capitalization is $8,866,605,056.

Over the last year, HSIC's share price has increased by 11.5%, which represents a difference of 0.4% when compared to the S&P 500. The stock's 52 week high is $82.49 per share whereas its 52 week low is $60.56. With average free cash flows of $552.98 Million that have been growing at an average rate of 4.4% over the last 5 years, Henry Schein is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 848,000 148,000 700,000 98.3
2023 500,000 147,000 353,000 -30.24
2022 602,000 96,000 506,000 -19.81
2021 710,000 79,000 631,000 14.73
2020 599,000 49,000 550,000 -4.82
2019 654,087 76,219 577,868
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS